CD8A and melanoma: Prf1 and Gzmb levels in melanoma tumors from control and compound mutant mice as well as those treated with Cbx3-Il21r- or Il21r-deficient CD8+ effector T cells were low compared to Cbx3/HP1γ-deficient mice (Figures 7A, B).